Cargando…
Rapid Evaluation of Antibody Fragment Endocytosis for Antibody Fragment–Drug Conjugates
Antibody–drug conjugates (ADCs) have emerged as the most promising strategy in targeted cancer treatment. Recent strategies for the optimization ADCs include the development of antibody fragment–drug conjugates (FDCs). The critical factor in the successful development of ADCs and FDCs is the identif...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7355425/ https://www.ncbi.nlm.nih.gov/pubmed/32630402 http://dx.doi.org/10.3390/biom10060955 |
_version_ | 1783558272304807936 |
---|---|
author | Kim, Eunhee G. Jeong, Jieun Lee, Junghyeon Jung, Hyeryeon Kim, Minho Zhao, Yi Yi, Eugene C. Kim, Kristine M. |
author_facet | Kim, Eunhee G. Jeong, Jieun Lee, Junghyeon Jung, Hyeryeon Kim, Minho Zhao, Yi Yi, Eugene C. Kim, Kristine M. |
author_sort | Kim, Eunhee G. |
collection | PubMed |
description | Antibody–drug conjugates (ADCs) have emerged as the most promising strategy in targeted cancer treatment. Recent strategies for the optimization ADCs include the development of antibody fragment–drug conjugates (FDCs). The critical factor in the successful development of ADCs and FDCs is the identification of tumor antigen-specific and internalizing antibodies (Abs). However, systematic comparison or correlation studies of internalization rates with different antibody formats have not been reported previously. In this study, we generated a panel of scFv-phage Abs using phage display technology and their corresponding scFv and scFv-Fc fragments and evaluated their relative internalization kinetics in relation to their antibody forms. We found that the relative rates and levels of internalization of scFv-phage antibodies positively correlate with their scFv and scFv-Fc forms. Our systematic study demonstrates that endocytosis of scFv-phage can serve as a predictive indicator for the assessment of Ab fragment internalization. Additionally, the present study demonstrates that endocytic antibodies can be rapidly screened and selected from phage antibody libraries prior to the conversion of phage antibodies for the generation of the conventional antibody format. Our strategic approach for the identification and evaluation of endocytic antibodies would expedite the selection for optimal antibodies and antibody fragments and be broadly applicable to ADC and FDC development. |
format | Online Article Text |
id | pubmed-7355425 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-73554252020-07-23 Rapid Evaluation of Antibody Fragment Endocytosis for Antibody Fragment–Drug Conjugates Kim, Eunhee G. Jeong, Jieun Lee, Junghyeon Jung, Hyeryeon Kim, Minho Zhao, Yi Yi, Eugene C. Kim, Kristine M. Biomolecules Article Antibody–drug conjugates (ADCs) have emerged as the most promising strategy in targeted cancer treatment. Recent strategies for the optimization ADCs include the development of antibody fragment–drug conjugates (FDCs). The critical factor in the successful development of ADCs and FDCs is the identification of tumor antigen-specific and internalizing antibodies (Abs). However, systematic comparison or correlation studies of internalization rates with different antibody formats have not been reported previously. In this study, we generated a panel of scFv-phage Abs using phage display technology and their corresponding scFv and scFv-Fc fragments and evaluated their relative internalization kinetics in relation to their antibody forms. We found that the relative rates and levels of internalization of scFv-phage antibodies positively correlate with their scFv and scFv-Fc forms. Our systematic study demonstrates that endocytosis of scFv-phage can serve as a predictive indicator for the assessment of Ab fragment internalization. Additionally, the present study demonstrates that endocytic antibodies can be rapidly screened and selected from phage antibody libraries prior to the conversion of phage antibodies for the generation of the conventional antibody format. Our strategic approach for the identification and evaluation of endocytic antibodies would expedite the selection for optimal antibodies and antibody fragments and be broadly applicable to ADC and FDC development. MDPI 2020-06-25 /pmc/articles/PMC7355425/ /pubmed/32630402 http://dx.doi.org/10.3390/biom10060955 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Kim, Eunhee G. Jeong, Jieun Lee, Junghyeon Jung, Hyeryeon Kim, Minho Zhao, Yi Yi, Eugene C. Kim, Kristine M. Rapid Evaluation of Antibody Fragment Endocytosis for Antibody Fragment–Drug Conjugates |
title | Rapid Evaluation of Antibody Fragment Endocytosis for Antibody Fragment–Drug Conjugates |
title_full | Rapid Evaluation of Antibody Fragment Endocytosis for Antibody Fragment–Drug Conjugates |
title_fullStr | Rapid Evaluation of Antibody Fragment Endocytosis for Antibody Fragment–Drug Conjugates |
title_full_unstemmed | Rapid Evaluation of Antibody Fragment Endocytosis for Antibody Fragment–Drug Conjugates |
title_short | Rapid Evaluation of Antibody Fragment Endocytosis for Antibody Fragment–Drug Conjugates |
title_sort | rapid evaluation of antibody fragment endocytosis for antibody fragment–drug conjugates |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7355425/ https://www.ncbi.nlm.nih.gov/pubmed/32630402 http://dx.doi.org/10.3390/biom10060955 |
work_keys_str_mv | AT kimeunheeg rapidevaluationofantibodyfragmentendocytosisforantibodyfragmentdrugconjugates AT jeongjieun rapidevaluationofantibodyfragmentendocytosisforantibodyfragmentdrugconjugates AT leejunghyeon rapidevaluationofantibodyfragmentendocytosisforantibodyfragmentdrugconjugates AT junghyeryeon rapidevaluationofantibodyfragmentendocytosisforantibodyfragmentdrugconjugates AT kimminho rapidevaluationofantibodyfragmentendocytosisforantibodyfragmentdrugconjugates AT zhaoyi rapidevaluationofantibodyfragmentendocytosisforantibodyfragmentdrugconjugates AT yieugenec rapidevaluationofantibodyfragmentendocytosisforantibodyfragmentdrugconjugates AT kimkristinem rapidevaluationofantibodyfragmentendocytosisforantibodyfragmentdrugconjugates |